Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
By John B. Buse, H. Ginsberg, G. Bakris, N. Clark, F. Costa, R. Eckel, V. Fonseca, H. Gerstein, S. Grundy, R. Nesto and 6 more. Diabetes Care, 2006
636 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology, Physiology
View Paper: https://www.semanticscholar.org/paper/e2d001741dffa90dfe359f620b660a7e01e41fe0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Pharmacology
Citations in the corpus
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials (2009, background): “For primary and secondary CVD risk reduction in patients with diabetes, providers should continue to follow the evidencebased recommendations for blood pressure treatment, including lipid-lowering with statins, aspirin prophylaxis, smoking cessation, and healthy lifestyle behaviors delineated in the”
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Primary prevention of cardiovascular diseases in people with diabetes mellitus AHA/ADA 2007 (36)”